Dissolving microneedle-assisted long-acting Liraglutide delivery to control type 2 diabetes and obesity
In this study, the capacity of 2 kinds of 500 μm and 1000 μm needles to deliver the desired dose of drug was obtained based on experimental and mathematical methods.PMID:34655736 | DOI:10.1016/j.ejps.2021.106040
Source: European Journal of Pharmaceutical Sciences - Category: Drugs & Pharmacology Authors: Morteza Rabiei Soheila Kashanian Gholamreza Bahrami Hossein Derakhshankhah Ebrahim Barzegari Seyedeh Sabereh Samavati Steven J P McInnes Source Type: research
More News: Alcoholism | Diabetes | Diabetes Type 2 | Drugs & Pharmacology | Eating Disorders & Weight Management | Endocrinology | Nanotechnology | Obesity | Study | Victoza